Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12323/4681Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Adli, Hawa | - |
| dc.date.accessioned | 2020-08-19T14:13:12Z | - |
| dc.date.available | 2020-08-19T14:13:12Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Khazar Journal of Science and Technology | en_US |
| dc.identifier.issn | 2520-6133 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12323/4681 | - |
| dc.description.abstract | The aim of this review was to summarize data from studies making inquiries on levels of the cytokines in pathogenesis of peri-implant diseases. Here we reviewed the recent developments on IL-1β, IL-10, IL-17, IL-21, and IL-33. We highlighted recent advances during the last few years in this area and discussed their roles in immune regulation in patients with peri-implant disease.Our results revealed that identifying the levels of these cytokines (IL-1β, IL-10, IL-17, IL-21, and IL-33) may help to predict the diagnosis of periimplant diseases. From a safety perspective, this study emphasized the need to consider the impact of these interleukin on peri-implant diseases. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Khazar University Press | en_US |
| dc.relation.ispartofseries | Vol. 4;№ 1 | - |
| dc.subject | Peri-implant diseases | en_US |
| dc.subject | cytokines | en_US |
| dc.subject | interleukins Introduction | en_US |
| dc.title | Cytokines and Peri-Implant Disease | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | 2020, Vol. 4, № 1 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Cytokines and Peri-Implant Disease.pdf | 162.04 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.